(Q45095320)

English

Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.

scientific article published in November 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Daniel J. Sargent

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Charles S. Fuchs

5

object named as

Charles S Fuchs

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Thierry Delaunoit

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Richard M Goldberg

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Roscoe F Morton

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Brian P Findlay

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sachdev P Thomas

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Muhammad Salim

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Paul L Schaefer

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Philip J Stella

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Erin Green

11

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

James A Mailliard

12

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

2170-2176

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective biomodulation by leucovorin of high-dose infusion fluorouracil given as a weekly 24-hour infusion: results of a randomized trial in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Early detection of toxicity and adjustment of ongoing clinical trials: the history and performance of the North Central Cancer Treatment Group's real-time toxicity monitoring program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Bolus fluorouracil and leucovorin with oxaliplatin as first-line treatment in metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20594

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20594

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45095320&oldid=1566614615"